(Reuters) – The world should be far better prepared for the next Ebola outbreak, with clinical trial results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus. A two-part shot from Johnson & Johnson and Danish partner Bavarian Nordic induced a durable immune response lasting... Read more